Clinical trials
Observational Obesity trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
93 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2005 | 1 |
| 2007 | 1 |
| 2009 | 2 |
| 2010 | 6 |
| 2011 | 6 |
| 2012 | 3 |
| 2013 | 1 |
| 2016 | 4 |
| 2017 | 9 |
| 2018 | 4 |
| 2019 | 5 |
| 2020 | 8 |
| 2021 | 3 |
| 2022 | 9 |
| 2023 | 7 |
| 2024 | 10 |
| 2025 | 7 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 28 |
| Unknown status | 24 |
| Recruiting | 21 |
| Active, not recruiting | 12 |
| Not yet recruiting | 3 |
| Enrolling by invitation | 3 |
| Withdrawn | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| China-Japan Friendship Hospital | 4 |
| The Third Xiangya Hospital of Central South University | 4 |
| Beijing Friendship Hospital | 3 |
| Dong Peng | 3 |
| First Affiliated Hospital of Chongqing Medical University | 3 |
| Huashan Hospital | 3 |
| Huazhong University of Science and Technology | 3 |
| Peking Union Medical College Hospital | 3 |
| Peking University | 3 |
| RenJi Hospital | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Obesity | 93 |
| Overweight | 29 |
| Metabolic Syndrome | 15 |
| Diabetes Mellitus, Type 2 | 13 |
| Hypertension | 10 |
| Diabetes Mellitus | 9 |
| Cardiovascular Diseases | 6 |
| Renal Insufficiency, Chronic | 4 |
| Sarcopenia | 4 |
| Stroke | 4 |
Trials
Showing 1 to 25 of 93. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.